Semaglutide Helps Young Adults with Severe Obesity

A new study found that semaglutide, marketed as Ozempic and Wegovy, significantly reduces BMI in young adults with treatment-resistant severe obesity following obesity care during childhood. The…

Continue Reading


News Source: www.labroots.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *